glp-1 receptor agonist type 1 diabetes randomized trial

glp-1 receptor agonist type 1 diabetes randomized trial Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Comparative effectiveness of GLP-1 receptor

Name: glp-1 receptor agonist type 1 diabetes randomized trial Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Comparative effectiveness of GLP-1 receptor
Brand: asscph.com
SKU: 24374308858
Price: 23.77 USD
Availability: InStock
Rating: 4.4995 (8 reviews)

SKU: 24374308858

4.5

USD23.77 USD70.77

Pay in 4 interest-free payments of $5.94 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Patients with significant gastroparesis, a condition involving delayed gastric emptying, may find that GLP-1 medications significantly worsen their symptoms given the medication's mechanism of action

472 It has been documented that KMT2A interacts with p65 transcription factor (p65 is also known as nuclear factor NF-kappa-B), which is essential for its recruitment on the promoter region of CATHEPSIN Z ( CTSZ ), which is one of the important downstream targets of KMT2A